RFK Jr. seeks to soften CDC vaccine recommendations, shifting flu & meningococcal vaccines to shared decision-making; CDC now ...
Ambros Therapeutics will take the Nasdaq spot of Werewolf Therapeutics, a cancer biotech that has been exploring strategic ...
Fresh off a new accelerated approval for its melanoma therapy, Replimune has named Michelle DiNapoli as chief commercial officer.
Genentech builds $750M OR facility; Bavarian Nordic delays Lyme vaccine to 2028; Xspray gets 2nd CRL for Dasynoc over ...
Moderna shares surged after positive Phase 3 results for its Merck-partnered melanoma cancer vaccine, boosting confidence in ...
FDA's TEMPO pilot added Limbic, Cadence & Dexcom, letting digital health firms skip premarket authorization in exchange for ...
In the amylin race, drug design appears to be a key differentiator. Later this year, Novo Nordisk’s CagriSema is ...
WuXi Bio divests its Bestchrom stake, Cabaletta adds ElevateBio alongside Lonza for rese-cel, and SK pharmteco expands its ...
China’s cheap, fast and quiet system for testing cutting-edge medicines is facing scrutiny after the deaths of three people in investigator-initiated trials.
FDA grants Ultragenyx's Genglycos accelerated approval, its first gene therapy, for GSDIa in patients 8 and up; list price $2 ...
Amgen ends TScan deal; Amylyx raises $350M; Enveda's ENV-308 safe in Phase 1; Kynexis extends Series A to $110M; Tolerance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results